Vik Chopra
Stock Analyst at Wells Fargo
(n/a)
# 4,408
Out of 4,414 analysts
15
Total ratings
n/a
Success rate
-14.5%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNMD CONMED | Maintains: Equal-Weight | $98 → $77 | $70.12 | +9.81% | 1 | Apr 25, 2024 | |
| SOLV Solventum | Initiates: Equal-Weight | $69 | $65.14 | +5.93% | 1 | Apr 8, 2024 | |
| MASI Masimo | Upgrades: Overweight | $117 → $160 | $136.25 | +17.43% | 5 | Mar 25, 2024 | |
| ENOV Enovis | Maintains: Overweight | $73 → $79 | $52.13 | +51.54% | 3 | Feb 23, 2024 | |
| GMED Globus Medical | Maintains: Equal-Weight | $63 → $58 | $50.48 | +14.90% | 5 | Sep 15, 2023 |
CONMED
Apr 25, 2024
Maintains: Equal-Weight
Price Target: $98 → $77
Current: $70.12
Upside: +9.81%
Solventum
Apr 8, 2024
Initiates: Equal-Weight
Price Target: $69
Current: $65.14
Upside: +5.93%
Masimo
Mar 25, 2024
Upgrades: Overweight
Price Target: $117 → $160
Current: $136.25
Upside: +17.43%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $52.13
Upside: +51.54%
Globus Medical
Sep 15, 2023
Maintains: Equal-Weight
Price Target: $63 → $58
Current: $50.48
Upside: +14.90%